![](https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg)
3 gene therapy companies secure VC money; Novalis closes nearly $30 million fund
A European life sciences VC firm will invest in three more startups specializing in rare genetic diseases as a part of its Sofinnova Telethon Fund …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.